These features make changes subtle, slow to appear, and harder to measure compared to visible inflammation in soft tissue
In clinical studies targeting obesity, particularly in the phase 3 trials based on the SURPASS program, tirzepatide demonstrated outstanding weight reduction benefits, with some patients achieving a weight loss of up to 22.5%
Whereas GLP-1 decreases plasma glucose levels by exerting insulinotropic effects, glucagon stimulates hyperglycemia by enhancing hepatic glucose output
For optimal results, a balanced diet and regular exercise are recommended alongside Tirzepatide B12 therapy
SIRT1, an NAD + -dependent class III histone deacetylase, regulates hepatic lipid metabolism through deacetylation of multiple transcription factors and metabolic enzymes, exerting a bidirectional effect on lipid homeostasis by inhibiting fat synthesis and promoting fatty acid oxidation
Cellular Longevity is ideal for clients whose primary goals are longevity, sleep, and internal markers, with aesthetic upgrades added separately
